Caroline Lonez
5PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Sep 15, 2025
Downregulation of MICA/MICB improves cell persistence and clinical activity of NKG2DL CAR T-cells in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasia.Daniel Pollyea, Tessa Kerre, Dries Deeren
|Feb 26, 2025
Clinical Proof-of-Concept of a Non-Gene Editing Technology Using miRNA-Based shRNA to Engineer Allogeneic CAR T-Cells.Caroline Lonez, Jennifer Bolsée, Fanny Huberty
|Jan 22, 2024
Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?Caroline Lonez, Eytan Breman
|Aug 01, 2019
Chimeric Antigen Receptor-T Cells for Targeting Solid Tumors: Current Challenges and Existing Strategies.Lorraine Springuel, Caroline Lonez, Bertrand Alexandre
|Nov 15, 2017
Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types.Caroline Lonez, Bikash Verma, Alain Hendlisz
Pageof 1
